Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)
Clinical trial NCT01841697 · COMPLETED
Trial details
- NCT number
- NCT01841697
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-13
- Primary completion
- 2014-11-17
- Enrollment
- 642
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.